[9/30/2005] Relìv International Surpasses Sales Milestone: Cumulative Sales of $1 Billion in Under 20 Years
Relìv International, Inc. (NasdaqNM - RELV), announced that it surpassed a sales milestone this month – when it recorded a cumulative total of $1 billion in sales since the company’s inception in 1988.
[9/30/2005] Integrated BioPharma Reports Results for Its Fiscal Year Ended
Integrated BioPharma Inc (INB) announced results for its fiscal year ended June 30, 2005. Revenues were $32.7 million, an increase of 29 percent over the prior year. The increase was attributable primarily to the introduction of new nutraceutical products.
[9/29/2005] Gulf Coast hurricanes disrupted Sysco Food Services
The recent GulfCoast hurricanes disrupted Sysco Food Services' ability to ship products through and near impacted areas. With the Federal Emergency Management Agency paying independent drivers three times what Sysco did, truckers became a prized commodity. Carl Cannova, president of Sysco Food Services, say business is retuning to normal but finding drivers is still an issue.
[9/28/2005] Production at Pasadena, Texas Joint Venture Facility Resumes
Canada Based Forbes Medi-Tech Inc. (TSX:FMI and NASDAQ:FMTI) announced that its Phyto-Source manufacturing facility in Pasadena, Texas, a 50-50 joint venture between Forbes and Chusei (USA) Inc., has resumed production of the Company's cholesterol-lowering ingredients with no apparent material property damage from the recent hurricane activity
[9/21/2005] Tate & Lyle Forms Global Food Ingredients Group
According to an article on just-food.com, UK-based ingredients company Tate and Lyle has announced the formation of a new global food ingredients group to be led by Mark White, currently chief executive of sugars, Europe.
[9/19/2005] Enzymatic Therapy Announces Formation of Holding Company
US-based supplement company Enzymatic Therapy, Inc. has announced that it has merged all of the operations of its wholly owned subsidiaries and created a holding company structure - ETI Holdings, Inc.
[9/19/2005] South Africa: Wellco Health Ltd. Set to Expand
According to a Reuters article, South Africa-based herbal supplement company Wellco Health Ltd. is set to list on the South African stock exchange with a 9 million rand (~1.42 million USD) placement. According to the article, the company plans to introduce its hangover product into Britain, Scandinavia, Russia and India.
[9/15/2005] Neptune Reports Year-end Results
Canada-based Neptune Technologies & Bioressources Inc. (TSX-V: NTB) has announced FY05 year end results, reporting sales of $5,038,000 compared to $2,262,000 in the previous year, with a et loss of $1,768,000 or $0.069 per share for quarter this year compared to $3,534,000 or $0.161 per share in the previous year.
[9/12/2005] Decas Botanical Synergies Announces OmegaCran(R) Cranberry Seed Oil Production Capacity Expansion
US-based ingredient company Decas Botanical Synergies (DBS), a division of Decas Cranberry Products, Inc., has announced a production capacity expansion for OmegaCran® in response to increased customer demand.
[9/9/2005] Martek Announces Third Quarter Financial Results
US-based Martek Biosciences Corporation (MATK) has announced FY05 Q3 results reporting revenues of $39.5 million, compared to $47.3 million for FY04 Q3, with a net loss of $100,000, or $0.00 per diluted share, compared to net income of $5.0 million, or $0.16 per diluted share, prior year.
[9/6/2005] Natural Alternatives International, Inc. Announces Revenue for Fiscal 2005
US-based supplement custom manufacturer Natural Alternatives International, Inc. (NAII) has announced FY05 results reporting revenue of $91.5 million compared to $78.5 million prior year, with net income of $2.2 million, ($0.34 per diluted share), compared to $3.0 million ($0.48 per diluted share) in the prior year.
[9/1/2005] The Hain Celestial Group Announces Fiscal Year and Fourth Quarter 2005 Results
US-based natural and organic food and personal care products company The Hain Celestial Group, Inc. (HAIN) has announced FY05 and Q4 results, reporting net sales for FY05 of $620.0 million, compared to $544.1 million the prior year, with net income for the year, excluding stock keeping unit rationalization and stock compensation charges, was $33.1 million,($0.89 per share), versus the prior year earnings of $27 million, ($0.74 per share).